Earth Science Tech, Inc. (ETST) Finishes Audit for Previous Years, Submits Form 10 to Become Fully Reporting
ETST now begins 2017 fiscal year audit, which is required along with the approved Form 10 to uplist to the OTCQB Biotech company is focused on developing medical devices for the pharmaceutical and nutraceutical fields and marketing high-grade hemp cannabidiol (CBD) In a news release, Dr. Michel Aube, CEO and chief science officer of ETST, says that, following completion of audit, he sees investor confidence growing and ETST seeking to secure its first big round of financing Earth Science Tech, Inc. (OTC: ETST) has announced completion of its audit for FY2015 and FY2016 and submitted its Form 10 to become…